These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22714752)

  • 1. The effect of isotretinoin on triglycerides and liver aminotransferases.
    Vieira AS; Beijamini V; Melchiors AC
    An Bras Dermatol; 2012; 87(3):382-7. PubMed ID: 22714752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral isotretinoin on lipids and liver enzymes in acne patients.
    Kızılyel O; Metin MS; Elmas ÖF; Çayır Y; Aktaş A
    Cutis; 2014 Nov; 94(5):234-8. PubMed ID: 25474452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isotretinoin therapy: any need for laboratory assessment?
    Tallab T; Joharji H; Jazei M; Bahamdan K; Ibrahim K; Karkashan E
    West Afr J Med; 2004; 23(4):273-5. PubMed ID: 15730082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
    Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
    JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal liver function tests in acne patients receiving isotretinoin.
    Pona A; Cardenas-de la Garza JA; Haidari W; Cline A; Feldman SR; Taylor SL
    J Dermatolog Treat; 2021 Jun; 32(4):469-472. PubMed ID: 31498706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin.
    Ferahbas A; Turan MT; Esel E; Utas S; Kutlugun C; Kilic CG
    J Dermatolog Treat; 2004 Jun; 15(3):153-7. PubMed ID: 15204147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term isotretinoin use does not cause parenchymal liver change: Ultrasonographic study in 50 patients.
    Aktas H; Ertugrul G; Parlak M; Unal M
    Dermatol Ther; 2019 Sep; 32(5):e13012. PubMed ID: 31241229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory tests in patients treated with isotretinoin: occurrence of liver and muscle abnormalities and failure of AST and ALT to predict liver abnormality.
    Webster GF; Webster TG; Grimes LR
    Dermatol Online J; 2017 May; 23(5):. PubMed ID: 28537864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of Laboratory Monitoring in Patients Taking Isotretinoin for Acne.
    Al-Haddab M; Alhuqayl A; Alsharif H; Alolyet D; Altaleb R
    Cutis; 2021 Jul; 108(1):43-45. PubMed ID: 34397358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotretinoin does not induce insulin resistance in patients with acne.
    Ertugrul DT; Karadag AS; Tutal E; Akin KO
    Clin Exp Dermatol; 2011 Mar; 36(2):124-8. PubMed ID: 20804507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective evaluation of routine isotretinoin laboratory monitoring in patients older than 35 years.
    Sharma P; Tkachenko E; Mostaghimi A
    J Am Acad Dermatol; 2021 Jan; 84(1):201-202. PubMed ID: 32344069
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over time.
    Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
    J Am Acad Dermatol; 2020 Jan; 82(1):72-79. PubMed ID: 31228528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
    Öktem A; Hayran Y; Arı E; Yalçın B
    J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
    [No Abstract]   [Full Text] [Related]  

  • 16. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
    Erturan İ; Naziroğlu M; Akkaya VB
    Cell Biochem Funct; 2012 Oct; 30(7):552-7. PubMed ID: 22517509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult women with acne have a higher risk of elevated triglyceride levels with the use of oral isotretinoin.
    Schmitt JV; Tavares M; Cerci FB
    An Bras Dermatol; 2011; 86(4):807-10. PubMed ID: 21987157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal Baseline Lab Results Rarely Lead to Treatment Modification for Patients on Isotretinoin.
    Tkachenko E; Sharma P; Mostaghimi A
    Dermatology; 2020; 236(6):517-520. PubMed ID: 32069457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized laboratory monitoring with use of isotretinoin in acne.
    Hansen TJ; Lucking S; Miller JJ; Kirby JS; Thiboutot DM; Zaenglein AL
    J Am Acad Dermatol; 2016 Aug; 75(2):323-8. PubMed ID: 27189824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.